Internal Medicine, Rheumatology · Dallas, TX
NPI
1720087414
Since 2005
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
8144 Walnut Hill Ln, Suite 800
Dallas, TX, 75231
Phone (214) 540-0700
Groups this clinician bills Medicare through
Medicare paid, 2024
$820K
154,520 services
Medicare patients, 2024
353
Average age 74
Drug cost, 2024
$899K
3,050 prescriptions
Company payments, 2025
$19K
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sharad Lakhanpal was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 137,200 times for 38 patients. In total Sharad Lakhanpal billed 154,520 services in 71 codes, and Medicare paid $820K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-08-06.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 137,200 | 38 | $3.62 | $497K |
| J0897 Injection, denosumab, 1 mg | Office | 2,940 | 28 | $20.01 | $59K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,900 | 37 | $0.10 | $193 |
| 80053 Clinical Chemistry | Office | 1,167 | 342 | $10.24 | $12K |
| 85025 Blood Count | Office | 1,155 | 341 | $7.53 | $8,702 |
| 85652 Clinical Chemistry | Office | 1,153 | 342 | $2.62 | $3,024 |
| 36415 Venipuncture Blood Collection | Office | 1,153 | 339 | $8.63 | $9,948 |
| 86140 Clinical Chemistry | Office | 1,150 | 342 | $5.03 | $5,782 |
| 99214 Office E&M - Established | Office | 1,028 | 317 | $87.89 | $90K |
| 96401 Chemotherapy Administration | Office | 730 | 66 | $56.13 | $41K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 655 | 266 | $12.37 | $8,103 |
| 81001 Clinical Chemistry | Office | 551 | 242 | $3.06 | $1,685 |
| 81003 Clinical Chemistry | Office | 548 | 226 | $2.20 | $1,206 |
| 82306 Clinical Chemistry | Office | 294 | 276 | $28.58 | $8,402 |
| 86160 Immunoassay | Office | 285 | 142 | $11.55 | $3,292 |
By year: 2022 $802K for 124,105 services; 2023 $885K for 160,391 services; 2024 $820K for 154,520 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80053 Clinical Chemistry | 1,167 | 342 | $10.24 | $12K |
| 85025 Blood Count | 1,155 | 341 | $7.53 | $8,702 |
| 36415 Venipuncture Blood Collection | 1,153 | 339 | $8.63 | $9,948 |
| 85652 Clinical Chemistry | 1,153 | 342 | $2.62 | $3,024 |
| 86140 Clinical Chemistry | 1,150 | 342 | $5.03 | $5,782 |
| 81001 Clinical Chemistry | 551 | 242 | $3.06 | $1,685 |
| 81003 Clinical Chemistry | 548 | 226 | $2.20 | $1,206 |
| 82306 Clinical Chemistry | 294 | 276 | $28.58 | $8,402 |
| 86160 Immunoassay | 285 | 142 | $11.55 | $3,292 |
| 86235 Immunoassay | 239 | 142 | $17.38 | $4,155 |
Medicare prescription drug claims, 2024
In 2024, the drug Sharad Lakhanpal prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 323 prescriptions and refills. In total Sharad Lakhanpal wrote 3,050 Medicare prescriptions that cost $899K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 323 | 754 | 106 | $12K |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 281 | 752 | 124 | $4,295 |
| Cyclobenzaprine Hcl Generic | 251 | 515 | 140 | $2,554 |
| Methotrexate Methotrexate Sodium | 228 | 505 | 82 | $4,543 |
| Meloxicam Generic | 221 | 499 | 99 | $1,063 |
| Celecoxib Generic | 186 | 388 | 78 | $9,658 |
| Sulfasalazine Generic | 184 | 399 | 69 | $4,986 |
| Etodolac Generic | 183 | 306 | 86 | $9,417 |
| Leflunomide Generic | 133 | 310 | 47 | $6,142 |
| Tizanidine Hcl Generic | 118 | 236 | 53 | $1,086 |
| Prednisone Generic | 114 | 186 | 28 | $686 |
| Sulfasalazine Dr Sulfasalazine | 81 | 185 | 27 | $3,679 |
| Diclofenac Sodium Generic | 77 | 147 | 46 | $4,594 |
| Tramadol Hcl Generic | 68 | 80 | 14 | $419 |
| Folic Acid Generic | 66 | 152 | 21 | $565 |
Brand drugs: - claims; generic drugs: 2,737 claims; opioid claims: 112.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sharad Lakhanpal $19K ($19K in general payments such as food, travel and fees) from 8 companies. The largest payer was Abbvie Inc. with $19K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.